CD47 and pancreatic adenocarcinoma: It was indicated that higher expression of CD47 predicted poor survival in ACC, KICH, KIRP, LGG, PAAD, and UCEC, while associated with favorable prognosis in SKCM, THCA, and THYM (Fig. 2A).